On September 17, 2021, the Pediatric Advisory Committee (PAC) will discuss pediatric-focused safety reviews, as mandated by the Best Pharmaceuticals for Children Act (Pub. L. 107-109) and the Pediatric Research Equity Act of 2003 (Pub. L. 108-155). The PAC will meet to discuss the following product:
Center for Devices and Radiological Health - FLOURISH Pediatric Esophageal Atresia Device (humanitarian device exemption).
Back to All Events
Earlier Event: September 2
Cellular, Tissue, and Gene Therapies Advisory Committee
Later Event: September 17
Vaccines and Related Biological Products Advisory Committee